 Connection
Boris Draznin to Prospective Studies
This is a "connection" page, showing publications Boris Draznin has written about Prospective Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.087 |
|
|
|
-
Hsia E, Seggelke S, Gibbs J, Hawkins RM, Cohlmia E, Rasouli N, Wang C, Kam I, Draznin B. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab. 2012 Sep; 97(9):3132-7.
Score: 0.040
-
Baran JD, Spanbauer C, Bais R, Chiang HH, Chao JH, Khakpour D, Panfil P, Pasquel FJ, Ullal J, Gligorijevic N, Jones MS, Low Wang CC, Buse JB, Draznin B, Sibayan J, Kollman C, Beck RW, Hirsch IB. Dexcom G7 Accuracy and Reproducibility in the Intensive Care Unit. Diabetes Technol Ther. 2025 Sep; 27(9):747-752.
Score: 0.025
-
Finlayson CA, Chappell J, Leitner JW, Goalstone ML, Garrity M, Nawaz S, Ciaraldi TP, Draznin B. Enhanced insulin signaling via Shc in human breast cancer. Metabolism. 2003 Dec; 52(12):1606-11.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|